Frailty, Sarcopenia, Cachexia, and Malnutrition in Heart Failure

被引:5
作者
Maeda, Daichi [1 ]
Fujimoto, Yudai [1 ]
Nakade, Taisuke [1 ]
Abe, Takuro [2 ]
Ishihara, Shiro [2 ]
Jujo, Kentaro [2 ]
Matsue, Yuya [1 ]
机构
[1] Juntendo Univ, Grad Sch Med, Dept Cardiovasc Biol & Med, 3-1-3 Hongo,Bunkyo Ku, Tokyo 1130033, Japan
[2] Saitama Med Univ, Saitama Med Ctr, Dept Cardiol, Saitama, Japan
基金
美国国家卫生研究院;
关键词
Heart failure; Frailty; Sarcopenia; Cachexia; Malnutrition; REDUCED EJECTION FRACTION; ASIAN WORKING GROUP; CONSENSUS REPORT; KOREAN SOCIETY; GLIM CRITERIA; OLDER; PREVALENCE; MUSCLE; MANAGEMENT; MORTALITY;
D O I
10.4070/kcj.2024.0089
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With global aging, the number of patients with heart failure has increased markedly. Heart failure is a complex condition intricately associated with aging, organ damage, frailty, and cognitive decline, resulting in a poor prognosis. The relationship among frailty, sarcopenia, cachexia, malnutrition, and heart failure has recently received considerable attention. Although these conditions are distinct, they often exhibit a remarkably close relationship. Overlapping diagnostic criteria have been observed in the recently proposed guidelines and position statements, suggesting that several of these conditions may coexist in patients with heart failure. Therefore, a comprehensive understanding of these conditions is essential, and interventions must not only target these conditions individually, but also provide comprehensive management strategies. This review article provides an overview of the epidemiology, diagnostic methods, overlap, and prognosis of frailty, sarcopenia, cachexia, and malnutrition in patients with heart failure, incorporating insights from the FRAGILEHF study data. Additionally, based on existing literature, this article discusses the impact of these conditions on the effectiveness of guideline-directed medical therapy for patients with heart failure. While recognizing these conditions early and promptly implementing interventions may be advantageous, further data, particularly from well-powered, large-scale, randomized controlled trials, are necessary to refine personalized treatment strategies for patients with heart failure.
引用
收藏
页码:363 / 381
页数:19
相关论文
共 100 条
  • [71] Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study
    Onder, G
    Penninx, BWJH
    Balkrishnan, R
    Fried, LP
    Chaves, PHM
    Williamson, J
    Carter, C
    Di Bari, M
    Guralnik, JM
    Pahor, M
    [J]. LANCET, 2002, 359 (9310) : 926 - 930
  • [72] Prognostic value of nutritional screening tools in hospitalized patients with decompensated heart failure: A systematic review and meta-analysis
    Osorio, Amanda Farias
    Ribeiro, edina Caroline Ternus
    Parahiba, Suena Medeiros
    Forte, Gabriele Carra
    Clausell, Nadine Oliveira
    Souza, Gabriela Correa
    [J]. NUTRITION RESEARCH, 2023, 120 : 1 - 19
  • [73] Frailty Is Intertwined With Heart Failure Mechanisms, Prevalence, Prognosis, Assessment, and Management
    Pandey, Ambarish
    Kitzman, Dalane
    Reeves, Gordon
    [J]. JACC-HEART FAILURE, 2019, 7 (12) : 1001 - 1011
  • [74] Reduced peripheral skeletal muscle mass and abnormal reflex physiology in chronic heart failure
    Piepoli, Massimo F.
    Kaczmarek, Agnieszka
    Francis, Darrel P.
    Davies, L. Ceri
    Rauchhaus, Mathias
    Jankowska, Ewa A.
    Anker, Stefan D.
    Capucci, Alessandro
    Banasiak, Waldemar
    Ponikowski, Piotr
    [J]. CIRCULATION, 2006, 114 (02) : 126 - 134
  • [75] The role of mineralocorticoid receptor antagonists (MRAs) in very old patients with heart failure
    Pitt, Bertram
    [J]. HEART FAILURE REVIEWS, 2012, 17 (4-5) : 573 - 579
  • [76] Are sarcopenia and its individual components linked to all-cause mortality in heart failure? A systematic review and meta-analysis
    Prokopidis, Konstantinos
    Triantafyllidis, Konstantinos Katsikas
    Kechagias, Konstantinos Spyridon
    Mitropoulos, Alexandros
    Sankaranarayanan, Rajiv
    Isanejad, Masoud
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2023, 114 (5) : 532 - 540
  • [77] Defining sarcopenia: some caveats and challenges
    Sanchez-Rodriguez, Dolores
    Marco, Ester
    Cruz-Jentoft, Alfonso J.
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2020, 23 (02) : 127 - 132
  • [78] The frailty syndrome and outcomes in the TOPCAT trial
    Sanders, Natalie A.
    Supiano, Mark A.
    Lewis, Eldrin F.
    Liu, Jiankang
    Claggett, Brian
    Pfeffer, Marc A.
    Desai, Akshay S.
    Sweitzer, Nancy K.
    Solomon, Scott D.
    Fang, James C.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (11) : 1570 - 1577
  • [79] Effect of frailty on treatment, hospitalisation and death in patients with chronic heart failure
    Sze, S.
    Pellicori, P.
    Zhang, J.
    Weston, J.
    Squire, I. B.
    Clark, A. L.
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2021, 110 (08) : 1249 - 1258
  • [80] Prognostic value of simple frailty and malnutrition screening tools in patients with acute heart failure due to left ventricular systolic dysfunction
    Sze, S.
    Zhang, J.
    Pellicori, P.
    Morgan, D.
    Hoye, A.
    Clark, A. L.
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2017, 106 (07) : 533 - 541